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ABSTRACT 
Cytomegalovirus (CMV) is a major public health problem throughout the world. It is the leading cause of congenital 
infections leading to neurological disabilities in children that result to severe sequelae such as sensor neural hearing loss, 
neuro-developmental delay and blindness. This study was conducted to determine the seroprevalence of human 
cytomegalovirus among pregnant women in Kaduna State, Nigeria. Three hundred and sixty three (363) blood samples 
were collected from 330 pregnant women attending antenatal clinics and 33 non pregnant women attending the Outpatient 
Department in three selected General Hospitals in Kaduna State. Serum obtained from the blood samples were examined 
for the presence of CMV IgG antibodies by IFA method. About 94.8% of pregnant women tested positive to CMV IgG 
antibodies while all (100%) of the non pregnant women tested positive. There was no statistically significant association 
between CMV and pregnancy (χ2=1.784, df=2, p=0.182). Infection with CMV was strongly associated with zone location 
(χ2=15.381, df,=2, p=0.000) and employment status of the women (χ2=5.519, df=1, p=0.018). There was no significant 
association between CMV infection and age, gravida, gestation age, education, number of marriages and history of 
previous transfusion. The high prevalence of CMV infection observed in this study indicates that the virus is prevalent in 
the study area and it is therefore advisable that routine screening of CMV infection be implemented for all antenatal 
women in the State.  
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RÉSUMÉ 
Le cytomégalovirus humain est un problème majeur de santé publique dans le monde entier. Il est la principale cause des 
infections congénitales conduisant à des séquelles neurologiques chez les enfants résultant des séquelles graves tels que la 
perte sensorielle de neurones auditifs, le retard de développement neurologique, la cécité. Cette étude a été menée pour 
déterminer la séroprévalence de cytomégalovirus humain parmi les femmes enceintes de l’Etat de Kaduna au Nigéria. Trois 
cents soixante trois (363) échantillons  du sang étaient collectés chez 330 femmes enceintes en consultation prénatale 
cliniques, 33 femmes non enceintes fréquentant le service de consultation externe de trois hôpitaux généraux sélectionnés 
dans l’Etat de Kaduna. Les sérums obtenus des échantillons sanguins ont été analysés par la méthode IFA  pour déterminer 
la présence des anticorps IgG anti-CMV. Environ 94,8% de femmes enceintes ont été testées positives aux anticorps anti-
CMV tandis que toutes les femmes non enceintes étaient positives (100%). Il n’y avait pas une association statistiquement 
significative entre le cytomégalovirus humain (HCMV) et la grossesse (χ2=1,784, ddl=2, p=0,182). Les infections au 
cytomégalovirus ont été fortement associées à l’emplacement de la zone (χ2=15,381, ddl=2, p=0,000) et le statut d’emploi de 
femmes (χ2=5,519, ddl=1, p=0,018). Il n'y avait pas d'association significative entre l'infection à cytomégalovirus humain 
(HCMV) et l'âge, gravida, l'âge de gestation, l'éducation, le nombre de mariages et l'antécédent de la transfusion 
précédente. La forte prévalence de l'infection à CMV observée dans cette étude indique que le virus est répandu dans la 
zone d'étude et il est donc souhaitable que le dépistage systématique de l'infection à cytomégalovirus doit être mis en 
œuvre pour toutes les femmes en consultations prénatales dans l'Etat. 
Mots clés: cytomégalovirus (CMV), IgG, femmes enceintes  




Cytomegalovirus (CMV) is a member of a family of 
8 human herpesviruses (HHV) designated as HHV 
type 5 [1]. It belongs to the subfamily 
Betaherpesvirinae and the family Herpesviridae. Other 
members of Betaherpesvirinae include HHV types 6 
and 7 which share common clinical characteristics 
with CMV [2]. Cytomegalovirus shares many 
attributes with other herpesviruses including 
genome, virion structures and ability to cause latent 
and persistent infection. It has a double stranded 
DNA with 162 hexagonal capsomeres surrounded 
by a lipid layer [2].  
 
Cytomegalovirus is mainly a problem for certain 
high risk groups which include unborn babies 
whose mothers become infected with CMV during 
pregnancy and children or adults whose immune 
systems have been weakened by disease or drug 
treatment such as organ transplant recipients or 
people infected with HIV [1,3]. It is a common 
opportunistic infection among Human 
immunodeficiency virus (HIV) infected individuals, 
a major source of viral complication among organ 
transplant recipients and a leading cause of hearing 
loss, vision loss and mental retardation among cv    
ongenitally infected children. More children suffer  
disabilities caused by congenital CMV than by 
several better known childhood maladies such as 
Down’s syndrome or foetal alcohol syndrome [4]. 
Each year about 1 in 150 babies is born with 
congenital CMV infection and about 8,000 children 
develop lasting disabilities caused by congenital 
CMV infection [5]. The virus is the leading cause of 
congenital infection affecting between 0.3-0.6% of 
all live births in Europe [6]. 
 
Cytomegalovirus is usually an asymptomatic 
infection. In immunocompetent individuals, 
symptomatic disease usually manifest as infectious 
mononucleosis. It is characterised by malaise, 
headache, sore throat and fatigue. Fever is also 
commonly present and may persist for weeks in 
98% of cases of cytomegalovirus mononucleosis. 
Lymphadenopathy, pharyngitis and splenomegaly 
are each seen in 30% of CMV patients [6].  
Other clinical abnormalities of CMV infection in 
normal host include Guillain-Barre, retinitis, 
thrombocytopenia, gastrointestinal ulceration, 
hepatitis and pneumonia [1,6].  In few cases, there 
are symptoms at birth which include premature 
delivery, being small for gestational age, jaundice, 
rashes and feeding difficulties [4].  
Cytomegalovirus is spread through close personal 
contact with people who excrete the virus in body 
fluids (e.g. saliva, urine, breast milk cervico-vaginal 
secretions and semen), by vertical transmission, 
through organ transplantation or via blood 
transfusion [6-8]. Mother to child transmission 
occurs by three routes described by Pass [6] which 
include ; transplacental, intra-uterine and breast 
milk transmission. 
 
Serological surveys have shown CMV infections in 
virtually every population that have been tested [9], 
with seropositivity ranging from 40 – 100% in 
different parts of the world [8,10]. For example, a 
serological survey of over 20,000 women in London 
found 54.4% of these women were seropositive for 
CMV [11]. It has been reported that African 
Continent has the highest prevalence of CMV IgG 
antibodies. Seroprevalence of 72.2%  and 96.0% 
have been reported in Western Sudan and Egypt 
[12]. In Asian countries such as Malaysia, the 
seroprevalence of CMV IgG antibodies among 
pregnant women was reported to be 84.0% [13]. In 
Nigeria, serological survey conducted in Bida, 
Lagos and Sokoto among pregnant women found a 
seroprevalence of 84.2%, 97.2% and 98.7% 
respectively [9, 14,15]. These results shows that 
CMV is on the rise in Nigerria.  
 
The prevalence of CMV has been studied in relation 
to other causes of congenital infections such as 
Toxoplasma gondii and rubella (TORCH agents) 
among pregnant women. In one of these 
comparative studies conducted in Turkey, CMV 
was found to be leading in prevalence with a 
seroprevalence of 96.4% for IgG, 0.7% for IgM and 
1.9% for IgG + IgM [16]. Similarly, a study in 
Turkey found  higher CMV seroprevalence of 94.4% 
for IgG and 0.4%  for IgM [17].  
 
Cytomegalovirus infection has been studied in 
relation to other infections in Nigeria. In a 
serological study carried out in Ibadan, Nigeria 
using complement fixation test (CFT), a 
seroprevalence of 86.6% among tuberculosis (Tb) 
patients, 50.6% among patients other than Tb 
patients and 54.6% among healthy blood donors 
was recorded. In general, a seroprevalence of 68.3% 
was obtained among all patients, with Tb patients 
having the highest rate [18]. Seroprevalence of CMV 
among blood donors in Nigeria is also high. 
Seroprevalence of 92.0% CMV IgG antibodies has 
been observed among blood donors in Jos [19]. 
Similarly, seroprevalence of CMV among paid and 
unpaid blood donors in Tirana, Albania gave an 
overall prevalence of 83% [10]. 
 
 A case was reported in 2004, of three siblings from 
a monogamous family in Osun State, Nigeria who 
presented with a history of visual 
impairment/blindness due to CMV [20].  
 
Primary infections occur between 1-4% in 
seronegative women during pregnancy and may be 
transmitted to foetus in 40% of cases [21-23]. 
Infected infants can develop hearing, vision, 
neurological and developmental problems over 
time. In a few cases, there are symptoms at birth 
which include premature delivery, being small for 
gestational age, jaundice, enlarged liver and spleen, 
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microcephaly, seizure, rashes and feeding 
difficulties [3,7].  
 
Nevertheless, there is little awareness of CMV 
among medical personnel and the general public 
[7]. Research indicates that fewer than half of the 
obstetricians in U.S talk to their pregnant women 
about CMV infection [5]. In the same vein, Nigerian 
medical personnel are hardly aware of the presence 
of this virus and the damage  it cause to the unborn 
foetuses, nor do they talk to their pregnant women 
about this virus. So seroprevalence studies of CMV 
in Nigeria are necessary to raise awareness of CMV 
infection and inform on appropriate and rational 
interventions in the country. 
                                                       
 MATERIALS AND METHODS                                             
A cross sectional study was carried out amongst 330 
pregnant women attending antenatal clinic in 
selected hospitals from each of the three 
geographical zones of Kaduna State. The hospitals 
were Hajiya Gambo Sawaba Hospital (HGSH),  
Zaria from the North zone, Yusuf Dan Tsoho 
Memorial Hospital (YDMH), Kaduna from the 
Central zone and General Hospital Kafanchan 
(GHK), from the South zone. 
Thirty three (33) female patients visiting the 
hospitals other than pregnant women were used as 
control population. From each woman, five ml 
(5ml) of blood was collected in plain vacuutainers, 
centrifuged on same day and the serum stored at -
20oC. All samples were screened for CMV IgG 
antibodies using Immunofluorescence Antibody 
(IFA) technique CMV IgG kit (Diagnostic 
Automation, Inc., Calabasas USA).  
 
Principles of Test 
The DAI fluorescent CMV-IgG antibody test system 
is designed to detect circulating CMV-IgG 
antibodies in human sera. The system employs 
CMV infected substrate cells and FITC-labeled goat 
anti-human IgG (γ chain specific) adjusted for 
optimum use dilution and free of nonspecific 
background staining. The reaction occurs in two 
steps: The first step is the interaction of CMV 
antibodies in patient sera with CMV infected 
substrate cells. The second is the interaction of 
FITC-labeled anti-human IgG (γ chain) with the 
CMV-IgG antibody attached to the CMV localized 
in the nucleus of the infected cells. 
 
Data Collection and Analysis 
Consenting participants were instructed to fill a 
questionnaire to obtain information on 
demography, risk factors, and reproductive 
characteristic. This information included age, town 
of residence, gravida, gestational age, educational 
status, occupation, marital status, number of 
marriages, history of blood transfusion and history 
of congenital deformity.  
Result and data from questionnaires were analysed 
using SPSS version 16 and the Pearson Chi square 
test at 95% confidence interval and a significance 
level of 0.05 was used to determine the 
relationships between the variables and 
seroprevalence rates. Consenting women were 
recruited between the months of January and April 
2011. Ethical approval was obtained from the 




The prevalence of Cytomegalovirus was found to 
be 94.8% (313/330) among pregnant women, and  
all (100%: 33/33) the non pregnant women had 
antibodies to CMV (Table 1). There was no 
significant difference in the prevalence of CMV  
infection between the pregnant and non pregnant 
women (χ2=1.784, df=1, P=0.182)   
Further analysis of the data based on geographical 
zoning, showed that there was a very strong 
significant difference in the distribution of CMV 
among the pregnant women by zonal location in 
Kaduna State (χ2=15.381,=df=2,=P=0.000). Women 
attending HGSH, Zaria from the North zone had 
the highest prevalence (99.1%: 109/110) while those 
attending YDMH, Kaduna from the Central zone 
had the lowest prevalence (88.2% : 97/110) (Table 2). 
 
Table 1: Seroprevalence of Cytomegalovirus among 













33 (100.0) 0 (0.0) 33 
Total 346 (95.3) 17 (4.7) 363 
 χ2=1.784, df=1, p=0.182 
 
Table 2: Seroprevalence of Cytomegalovirus among 






GHK 107 (97.3) 3 (2.7) 110 
HGSH 109 (99.1) 1 (0.9) 110 
YDMH 97 (88.2) 13 (11.8) 110 
TOTAL 313 (94.8) 17 (15.5) 330 
                          χ2=15.381, df=2, p=0.000 
Key: YDMH = Yusuf Dan-Tsoho Memorial Hospital. 
HGSH= Hajiya Gambo Sawaba Hospital. 
GHK= General Hospital Kafanchan. 
Age as a risk factors for CMV infection was 
considered in this study and classified into seven 
groups. The result shows that there was no 
significant difference between age group and CMV 
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infection (χ2=8.790, df=6, p = 0.186). All the women 
in  both age group 15-19 and >44 years had highest 
IgG anitibodies to CMV while women in age group 
40-44 had the lowest prevalence (85.7%: 6/7) (Table 
3). 
 
Table 3: Seroprevalence of Cytomegalovirus among 





Negative (%) Total 
15-19 24 (100.0) 0 (0.0) 24 
20-24 116 (98.3) 2 (1.8) 118 
25-29 79 (90.8)  8 (9.2) 87 
30-34 60 (93.8) 4 (6.3) 64 
35-39 26 (92.9) 2 (7.1) 28 
40-44 6  (85.7) 1 (14.3) 7 
>44 2 (100.0) 0 (0.0) 2 
Total 313 (94.8) 17 (5.4) 330 
χ2=8.790, df=6, p=0.186 
 
Analysis of the result based on gravda shows that 
there was no significant difference between CMV 
infection and gravida (χ2=0.889, df=4, p= 0.927).  All 
women  with gravida above 8 had antibodies  to 
CMV (100%: 15/15) and the lowest prevalence rate 
was recorded among women with gravida 7-8  
(94.3%: 33/35) (Table 4). 
 
Table 4: Seroprevalence of CMV among Pregnant 
Women in Kaduna State by  Number of Gravida        
Gravida Positive (%) Negative  
(%)  
Total 
1-2 111 (94.9) 6 (5.1) 117 
3-4 85 (94.4) 5 (5.6) 90 
5-6 69 (94.5) 4 (5.5) 73 
7-8 33 (94.3) 2 (5,7) 35 
>8 15 (100.0) 0 (0.0) 15 
Total 313 (94.8) 17 (5.2) 330 
χ2=0.884, df=4, P=0.927 
 
Further, analysis of risk factors for CMV infection 
among the pregnant women based on gestation 
period showed that there was no significant 
difference between gestation and CMV infection 
(χ2=1.661, df=2, p=0.436). Highest prevalence was 
however recorded in the second trimester (95.8%: 
207/216) while the lowest was recorded in the third 
trimester (Table 5).  
 
Analysis of the the prevalence obtained based on 
blood transfusion in this study also showed that 
there was no association between transfusion and 
CMV infection (χ2=0.074, df=1, p=0.789). A higher 
prevalence rate of 94.9%; (299/315) was however 
recorded among women that had never undergone 
transfusion against those who had (93.3%: 14/15) 
(Table 6)  
 
Further analysis of the results based on socio-
demographic data such as employment status, 
educational status and number of marriages shows 
that there was no statistically significant association 
between the virus and educational status and 
number of marriages the women had been in 
(p>0.05). There was however a strong association 
between CMV infection and employment 
(p=0.0180). Highest seroprevalence of CMV was 
obtained among women with no formal education 
(95.9%: 70/73) and the lowest among women who 
reached tertiary levels of education (90.3%: 28/33) 
(Table 7) 
 
Table 5: Seroprevalence of CMV among Pregnant 








First trimester 22 (95.7) 1 (4.3) 23 
Second 
trimester 
207 (95.8) 9 (4.2) 216 
Third 
trimester 
84 (92.3) 7 (7.7) 91 
Total 313 (94.8) 17 (5.2) 330 
χ2 =1.661, df=2, P=0.436 
 
 
Table 6: Seroprevalence of Cytomegalovirus Infection in 
Pregnant Women in Relation to History of Blood 






Negive (%) Total 
Not 
transfused 
299 (94.9) 16 (5.1) 315 
Transfused 14 (93.3) 1 (6.7) 15 
Total 313 (94.8) 17 (5.2) 330 
 χ2=0.074, df=1, P=0.789 
 
DISCUSSION 
The results obtained from this study show that the 
seroprevalence rate of CMV infection among 
pregnant women in Kaduna State is high. A 
seroprevalence of 94.8% was obtained in this study. 
This result is similar to the seroprevalence of 84.2% 
among pregnant women reported in Bida, Nigeria, 
97.2% among pregnant women reported in Lagos, 
Nigeria and 98.7% among pregnant women 
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reported in Sokoto State, Nigeria [9,14,15]. This 
prevalence agrees with the assertion of Saraswathy 
et al. [13], that African continent has the highest 
prevalence rate of CMV IgG antibodies. 
 
There was no significant association between the 
seroprevalence of CMV in pregnant and non 
pregnant women. This could be due to the low 
sample size of non pregnant women compared to 
that of pregnant women. However the result is 
similar to that reported in Southeast Brazil [24]. The 
reason for the high prevalence of CMV infection 
among pregnant women in Kaduna State may not 
be unconnected to the depreciating socioeconomic 
standard, poor hygienic practices and low standard 
of education among these women.  
 
High seroprevalence of CMV infection in Kaduna 
State may have serious consequences on children in 
Kaduna State. It has been reported, that the 
incidence of congenital CMV infection depends on 
epidemiological characteristics of a population, in 
particular the maternal CMV seroprevalence [25]. 
High rates of congenital CMV infection have been 
consistently demonstrated in populations with high 
CMV seroprevalence [25]. Hence, the high 
prevalence rate of CMV infection among pregnant 
women in Kaduna state implies there might be a 
corresponding high incidence of congenital CMV 
infection among infants born in the state. In the 
study carried out by Mussi-Pinhata et al. [25],  it 
was found that congenital CMV disease occurs in 
populations with high seroprevalence rates, with a 
similar incidence of CMV-related hearing loss. This 
also implies that there may be increased incidence 
of congenital CMV infection among infants in 
Kaduna state as a result of high seroprevalence of 
CMV infection in pregnant women; This might also 
lead to a similar increase in the incidence of CMV-
related hearing and vision loss in children in the 
state.   
 
Table 7: Seroprevalence of Cytomegalovirus among Pregnant Women in Kaduna State by Sociodemographic Data 
 
Variable No Positive (%) No Negative (%) Total p-value 
No of marriages     
1 290 (95.1) 15 (4.9) 305  
2 22 (91.7) 2 (8.3) 24 0.746 
3 1 (100) 0 (0.0) 1  
Employment     
No 200 (97.1) 6 (2.9) 206  
Yes 113 (91.1) 11 (8.9) 124 0.018 
Education     
No formal education 70 (95.9) 3 (4.1) 73  
Primary 79 (95.2) 4 (4.8) 83 0.682 
Secondary 136 (95.1) 7 (4.9) 143  




   
42 
 
There was a strong association between the 
seroprevalence of CMV infection and zone of 
location of the women ; with Zaria zone having the 
highest seroprevalence rate and Kaduna zone 
having the lowest. Most of the women enrolled in 
the study from Zaria zone were resident in Zaria 
City where there is overcrowding and congestion of 
settlement leading to poor hygiene and condition of 
living. It was also noticed that majority of women 
from Zaria zone have low education and are non 
employed which could possibly account for the 
highest seroprevalence [12]. The lowest prevalence 
rate obtained in Kaduna zone might be as a result of 
enlightenment as the women are more educated 
and have better hygienic environments  and 
condition of living. This result agrees with the 
report of Ludwig and Hengel [7] who asserted that 
sereoprevalence of CMV differs between countries 
and regions. 
 
There was no association between women who had 
been transfused and those that were not and 
seroprevalence was higher among those that were 
not transfused than those that had been transfused 
This result disagrees with the report of Matos et al. 
[8] where blood transfusion was  shown to be a risk 
factor for transmission of CMV infection. The 
reason for the disagreement here could be as a 
result of the disproportionate size of women who 
were transfused to those who were not transfused 
enrolled in the study.  
 
Analysis of the result by age shows that there was 
no significant association between CMV and age 
contrary to previous report [9, 26] that used ELISA 
method. There was no predictable pattern between 
seroprevalence and age, even though the youngest 
and oldest age gave the highest prevalence. The 
highest seroprevalence among the youngest age 
group could be explained by increase sexual 
activities of this age group as the virus can be 
transmitted sexually while longer duration of 
exposure to the virus might be responsible for the 
highest prevalence seen in the older age group.  
 
Eventhough the seroprevalence of CMV was 
highest in the second trimester, there was no 
significant difference between the seroprevalence 
and gestation period. This result agrees with 
previous findings [9,15] and could be due to the fact 
that most pregnant women report for antenatal in 
their second trimester than in the first and third 
trimester. 
 
Similarly, there was no significant association 
between gravida and CMV infection in this study 
and this agrees with the findings of Okwori et al. 
[9]. The pattern of change of seroprevalence with 
gravida was not clear in this study, though the 
highest prevalence rate was found in gravida >8. 
This result agrees with the findings of Hamdan et 
al.  [12] that reported high gravida to be a 
significant risk factor for CMV infection. This could 
be so as increase in gravida could imply increase in 
parity which also implies increase in age, which 
according to previous reports [7, 26] is a significant 
predictor of CMV infection.  
 
Seroprevalence of CMV infection by employment 
status which is one of the predictors of 
socioeconomic status was higher among the non 
employed. There was a strong association between 
employment status and CMV infection in this 
study. Socioeconomic status has been shown to be a 
risk factor for CMV infection [27]. The reason for 
this is probably because, high socioeconomic status 
implies ability to acquire education and afford 
better and healthy living conditions which 
decreases exposure to the virus. 
 
The distribution of seroprevalence rates of CMV 
infection among pregnant women by number of 
marriages shows that women who had been 
involved in up to three marriages in their life time 
had the highest seroprevalence rate. However this 
difference was not statisticall significant. This result 
disagrees with previous findings [26]. This 
observed non statistical difference may have arisen 
from the disproportionate composition of women in 
the various groups.  
 
In this study, the seroprevalence rate decreased 
insignificantly with increase in education. The 
decrease in seroprevalence agrees with a previous 
report [12] that showed that illiterate women are at 
higher risk of CMV infection due to contact with 
contagious secretions from their own children and 




The seroprevalence of 94.8% obtained in this study 
shows that CMV is highly associated with pregnant 
women in Kaduna State. The impliies that there 
might be a corresponding increase in the incidence 
of congenital CMV infection hence similar increase  
in the incidence of CMV-related hearing loss, vision 
loss, microcephaly and poor mental development 
among children in Kaduna State.  Zone location and 
employment status were statistically associated 
with CMV infection. Other risk factors such as 
history of blood transfusion, gestation, parity, 
number of marriages and educational status did not 
show any significant association.  
 
RECOMMENDATIONS 
There is no licenced vaccine so far against 
Cytomegalovirus infection except those currently 
under investigation [12]. Hence, the only means to 
prevent transmission of CMV among pregnant 
women is to create awareness through health talk 
during antenatal on the transmission, consequences 
of infection on foetus and its control and preventive 
measures. 
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Routine screening of pregnant women for CMV 
should be adopted in all health care facilities and 
blood should be  properly screened for CMV before 
transfusion to pregnant women. 
Babies born to seropositive mothers should be 
screened and examined immediately after delivery 
for possible signs of hearing and vision defects for 
early management.  
More studies are required in order to ascertain the 
incidence rate of CMV infection among pregnant 
women in Kaduna State through determination of 
IgM and IgG avidity test.  
  
LIMITATIONS 
There were no sufficient funds to have expanded 
this study in order to include the determination of 
IgM antibody for recent infections. Access to 
pregnant and non pregnant women was difficult as 
medical officers in the hospitals were not willing to 
assist. There was also the problem of getting true 
information from the women as many of them 
would not want to disclose certain information 
because of confidentiality. 
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